1.
Chinese Journal of Radiation Oncology
;
(6): 913-918, 2020.
Article
in Chinese
| WPRIM
| ID: wpr-868705
ABSTRACT
In 2018, studies of radiotherapy for breast cancer mainly focus on three aspects: shorten course of radiotherapy: efficacy and safety of weekly hypofractionated whole breast irradiation (FAST and FAST FORWARD) and dose escalated intensity-modulated radiotherapy to whole breast (IMPORT HIGH); reduction in treatment volume: safety and efficacy of APBI (NSABP/RTOG 0413 and RAPID), and individualize radiotherapy decision: optimization of definition of low-risk breast cancer using clinicopathologic parameters, genomic assays and molecule subtypes. The individualized radiotherapy will be the mainstream orietation of development.